New cholesterol drug passes first safety check in healthy people
NCT ID NCT06732154
First seen Apr 04, 2026 · Last updated May 12, 2026 · Updated 2 times
Summary
This early-stage study tested a single injection of a new drug called HRS-5632 in 50 healthy adults to see if it is safe and how the body processes it. The goal is to eventually treat dyslipidemia (abnormal cholesterol levels). Since it is a Phase 1 trial in healthy people, it focuses on safety, not on treating the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality, 300052, China
Conditions
Explore the condition pages connected to this study.